Benin Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
Benin Management's OVID Position: Q3 2026 in Review
Benin Management held its Ovid Therapeutics (OVID) position steady in Q3 2026 at 19,000 shares worth $47.3K. The position accounts for 0.01% of the portfolio, ranked #150.
Benin Management first reported a position in OVID in Q4 2025 and has held it in 4 quarters since. The position peaked at $51.1K in Q2 2026. 81 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- Benin Management held 19,000 shares of Ovid Therapeutics worth $47.3K as of Q3 2026.
- Benin Management left its Ovid Therapeutics share count unchanged in Q3 2026.
- Ovid Therapeutics made up 0.01% of Benin Management's portfolio in Q3 2026, its #150 holding.
- Benin Management first reported a position in Ovid Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Benin Management's Ovid Therapeutics position peaked at $51.1K in Q2 2026.
- 81 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on Benin Management's 13F filing for Q3 2026, filed 22 Oct 2026.